Uniphar Plc Eo Stock EBITDA

0NR Stock  EUR 2.08  0.06  2.97%   
UNIPHAR PLC EO fundamentals help investors to digest information that contributes to UNIPHAR PLC's financial success or failures. It also enables traders to predict the movement of UNIPHAR Stock. The fundamental analysis module provides a way to measure UNIPHAR PLC's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to UNIPHAR PLC stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

UNIPHAR PLC EO Company EBITDA Analysis

UNIPHAR PLC's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

EBITDA

 = 

Revenue

-

Basic Expenses

More About EBITDA | All Equity Analysis

Current UNIPHAR PLC EBITDA

    
  68.23 M  
Most of UNIPHAR PLC's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, UNIPHAR PLC EO is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Competition

According to the company disclosure, UNIPHAR PLC EO reported earnings before interest,tax, depreciation and amortization of 68.23 M. This is 92.22% lower than that of the Healthcare sector and significantly higher than that of the Medical Care Facilities industry. The ebitda for all Germany stocks is 98.25% higher than that of the company.

Did you try this?

Run Bond Analysis Now

   

Bond Analysis

Evaluate and analyze corporate bonds as a potential investment for your portfolios.
All  Next Launch Module

UNIPHAR Fundamentals

About UNIPHAR PLC Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze UNIPHAR PLC EO's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of UNIPHAR PLC using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of UNIPHAR PLC EO based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in UNIPHAR Stock

UNIPHAR PLC financial ratios help investors to determine whether UNIPHAR Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in UNIPHAR with respect to the benefits of owning UNIPHAR PLC security.